For informational and research purposes only.
Research, explained. Explore peptides, supplements and hormone health with clear, practical breakdowns of what the studies actually tell us.
Metabolism, recovery and emerging research
Geref had specific historical approvals. Understand their withdrawal, FDA's later determination and why a compounded sermorelin product has a separate status.
Read articleTesamorelin’s visceral-fat results concern a specific tissue and clinical population. Learn what they do—and do not—say about weight and body shape.
Read articleThe corrected TESTS trial did not demonstrate a sepsis survival benefit from thymosin alpha-1. Its results show why an immune mechanism needs a clinical test.
Read articleWhat trial-quality retatrutide means, why purity is only one question, and what an online vial's name or certificate cannot establish.
Read articleCagriSema trials, tirzepatide comparisons and a newly listed add-on study answer different questions. Here is what each can support.
Read articleSS-31 and MOTS-c have different roles in mitochondrial research. Human studies explain some of the interest, but do not establish a benefit from using them in sequence.
Read articleBiopsy findings, MRI liver-fat changes and weight loss answer different questions in survodutide's liver research.
Read articleThe phase 3 trial's treatment stops, continued follow-up and statistical analyses explain why its weight-loss estimates differ.
Read articleThree randomized trials offer a more precise picture of semaglutide and alcohol use: improvements in some drinking measures, with important gaps in others.
Read articleThe STEP extension found substantial average weight regain after treatment ended. Learn what the numbers mean and how maintenance trials change the interpretation.
Read articleTesamorelin can reduce visceral fat while glucose still needs attention. Here is how the trials, diabetes signal and different blood tests fit together.
Read articleA 2025 feline trial separates changes in a blood marker from the outcome owners care about: remaining free of insulin treatment.
Read article13–24 of 320 articles
